Sarcoma, Ewing Clinical Trial
Official title:
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma
Extraction of laboratory data from blood tests prior to surgical and chemotherapy and other histological, clinical and instrumental data related to the patient's history from the digitized medical Digitized medical records and analysis of the same. The medical records of 1000 patients from January 1, 2000, until December 31, 2020
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05440786 -
CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
|
Phase 2 | |
Completed |
NCT01661400 -
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
|
Phase 1 | |
Completed |
NCT03275818 -
Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma
|
Phase 2 | |
Recruiting |
NCT05046314 -
A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma
|
Phase 2 | |
Recruiting |
NCT06387485 -
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
|
N/A | |
Active, not recruiting |
NCT02415816 -
Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas
|
N/A | |
Not yet recruiting |
NCT04890093 -
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03778996 -
SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma
|
Phase 2 | |
Terminated |
NCT02581384 -
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT05772312 -
Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery
|
||
Withdrawn |
NCT02557854 -
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
|
Phase 1 | |
Terminated |
NCT03495921 -
A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide
|
Phase 3 | |
Terminated |
NCT02657005 -
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
|
Phase 1/Phase 2 |